PC
CRNX icon

Pier Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Pier Capital’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,000
Closed -$3.12M – 136
2025
Q3 		$3.12M Sell
75,000
-67,611
-47% -$2.16M 0.49% 94
2025
Q2 		$4.1M Buy
142,611
+29,199
+26% +$902K 0.63% 77
2025
Q1 		$3.8M Buy
113,412
+1,413
+1% +$52.8K 0.64% 76
2024
Q4 		$5.73M Buy
111,999
+3,638
+3% +$204K 0.82% 74
2024
Q3 		$5.54M Sell
108,361
-184
-0.2% -$9.49K 0.78% 71
2024
Q2 		$4.86M Sell
108,545
-8,025
-7% -$371K 0.72% 73
2024
Q1 		$5.46M Sell
116,570
-33
-0% -$1.29K 0.75% 67
2023
Q4 		$4.15M Buy
+116,603
New +$3.58M 0.59% 82

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return